Article
Autophagy in Chronic Myeloid Leukaemia: Stem Cell Survival and Implication in Therapy
31 Aug 2013
Abstract excerpt
The insensitivity of Chronic Myeloid Leukaemia (CML) stem cells to Tyrosine Kinase Inhibitor (TKI) treatment is now believed to be the main reason for disease persistence experienced in patients. It has been shown that autophagy, an evolutionarily conserved catabolic process that involves degradation of unnecessary or harmful cellular components via lysosomes, is induced following TKI treatment in CML cells. Of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
